Rafferty Asset Management, LLC Sutro Biopharma, Inc. Transaction History

Rafferty Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$4.48 - $8.45 $524,572 - $989,427	117,092 Added 118.71%	215,729 $996,000
Q4 2022 Feb 13, 2023	BUY	$5.41 - $8.08 $533,626 - $796,986	98,637 New	98,637 $796,000
Q2 2022 Aug 12, 2022	SELL	$3.41 - $8.95 $561,933 - $1.47 Million	-164,790 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$7.78 - $15.31 $650,882 - $1.28 Million	83,661 Added 103.12%	164,790 $1.36 Million
Q4 2021 Feb 10, 2022	BUY	$14.25 - $23.53 $362,235 - $598,132	25,420 Added 45.63%	81,129 $1.21 Million
Q3 2021 Nov 10, 2021	SELL	$16.88 - $22.38 $547,924 - $726,454	-32,460 Reduced 36.82%	55,709 $1.05 Million
Q2 2021 Aug 10, 2021	SELL	$18.03 - $23.82 $885,886 - $1.17 Million	-49,134 Reduced 35.79%	88,169 $1.64 Million
Q1 2021 May 10, 2021	BUY	$20.29 - $27.54 $2.79 Million - $3.78 Million	137,303 New	137,303 $3.13 Million

140

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $98.1M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.